DEV — test website with test data. Orders here are not real and nothing is shipped or charged.

Tech support 866-350-1500

Pay by PO: enter it at checkout

Neuromics
Log in

Publications

Published research that used Neuromics reagents, with the products each paper cites. Search, or narrow by product family and year.

Papers
672
Products cited
176

Papers that used proDynorphin (GP10110)Show all products

All familiesPrimary Antibody 6
Any year2020 on 52015–2019 32010–2014 6Before 2010 6

6 of 672 papers

  1. Nociceptin/Orphanin FQ Peptide in Hypothalamic Neurones Associated with the Control of Feeding Behaviour

    N. Maolood and B. Meister · Journal of Neuroendocrinology, Volume 22 Issue 2, Pages 75 - 82 · 2009

    Products used

  2. Intravenous Ibandronate Rapidly Reduces Pain, Neurochemical Indices of Central Sensitization, Tumor Burden, and Skeletal Destruction in a Mouse Model of Bone Cancer

    Kyle G. Halvorson, BA, Molly A. Sevcik, BA, Joseph R. Ghilardi, BS, BA, Lucy J. Sullivan, BA, Nathan J. Koewler, BS, Frieder Bauss, PhD, and Patrick W. Mantyh, PhD · J Pain Symptom Manage · 2008

    Products used

  3. Increased spinal dynorphin contributes to chronic nicotine-induced mechanical hypersensitivity in the rat

    Chris Lough, Tracey Young, Renee Parker, Shannon Wittenauer and Michelle Vincler · Neuroscience Letters · 2007

    Products used

  4. Spinal cord dynorphin expression increases, but does not drive microglial prostaglandin production or mechanical hypersensitivity after incisional surgery in rats

    Xiaying Zhua, Michelle A. Vincler, Renee Parker and James C. Eisenach · PAIN · 2006

    Products used

  5. Multiple actions of systemic artemin in experimental neuropathy

    Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossimando AJ, Miller S, Buckley C, Cai AK, Tse A, Foley SF, Gong B, Walua L, Carmillo P, Worley D, Huang C, Engbeer T, Pepinsky B, Cate RL, Vanderah TW, Lai J, Sah DWY, Porreca F · Nature, Med. 9: 1383-1389 · 2003

    Products used

  6. Simultaneous Reduction in Cancer Pain, Bone Destruction, and Tumor Growth by Selective Inhibition of Cyclooxygenase-2

    Sabino MC, Ghilardi JR, Jongen JLM, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW · Cancer Resear., 62:7343-7349 · 2002

    Products used